Mes: noviembre 2024
Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
Genetics of Parkinson’s disease: Dominant forms and GBA
Parkinson’s disease (PD) accounts for a significant burden on modern society, with an increasingly rapid growth in cases. Variants of several genes have been linked to the risk of developing the disease (e.g., the GBA […]
Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillation
Introduction Direct oral anticoagulants (DOACs) are the first line of stroke prevention treatment in patients with non-valvular atrial fibrillation (NVAF). However, their inappropriate use is associated with increased risk of stroke, haemorrhagic complications, and mortality. […]
Clinical characteristics of ultra-longitudinally extensive transverse myelitis in a Peruvian cohort
Introduction Ultra-longitudinally extensive transverse myelitis (uLETM) is defined as an inflammatory lesion involving 10 or more spinal cord segments. The aim of our study is to describe the clinical and radiological features of this atypical […]
Relationship between brain-derived neurotrophic factor and mild to moderate cognitive impairment in the older Mexican population
Background Mild–moderate cognitive impairment is a frequent pathology in the adult population. It is important to explore early expression biomarkers that contribute to early detection and benefit the prognostic outlook. Brain-derived neurotrophic factor (BDNF) is […]
Post-stroke sexual dysfunction in males
Introduction Sexual dysfunction (SD) is a commonly overlooked issue following ischemic stroke (IS), influenced by various risk factors including social, psychological, and biological factors. This study aims to investigate the prevalence and risk factors associated […]